Index
1 Market Overview
1.1 Product Overview and Scope of Monoclonal Antibody Development Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Monoclonal Antibody Development Services by Type
1.3.1 Overview: Global Monoclonal Antibody Development Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Monoclonal Antibody Development Services Consumption Value Market Share by Type in 2022
1.3.3 Small-scale
1.3.4 Medium-sclae
1.3.5 Large-scale
1.4 Global Monoclonal Antibody Development Services Market by Application
1.4.1 Overview: Global Monoclonal Antibody Development Services Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Biopharmaceuticals
1.4.3 Medical Diagnosis
1.4.4 Agricultural
1.4.5 Medical Treatment
1.4.6 Environmental monitoring
1.4.7 Others
1.5 Global Monoclonal Antibody Development Services Market Size & Forecast
1.6 Global Monoclonal Antibody Development Services Market Size and Forecast by Region
1.6.1 Global Monoclonal Antibody Development Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Monoclonal Antibody Development Services Market Size by Region, (2018-2029)
1.6.3 North America Monoclonal Antibody Development Services Market Size and Prospect (2018-2029)
1.6.4 Europe Monoclonal Antibody Development Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Monoclonal Antibody Development Services Market Size and Prospect (2018-2029)
1.6.6 South America Monoclonal Antibody Development Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Monoclonal Antibody Development Services Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Eurogentec
2.1.1 Eurogentec Details
2.1.2 Eurogentec Major Business
2.1.3 Eurogentec Monoclonal Antibody Development Services Product and Solutions
2.1.4 Eurogentec Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Eurogentec Recent Developments and Future Plans
2.2 ProSci
2.2.1 ProSci Details
2.2.2 ProSci Major Business
2.2.3 ProSci Monoclonal Antibody Development Services Product and Solutions
2.2.4 ProSci Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ProSci Recent Developments and Future Plans
2.3 Syd Labs
2.3.1 Syd Labs Details
2.3.2 Syd Labs Major Business
2.3.3 Syd Labs Monoclonal Antibody Development Services Product and Solutions
2.3.4 Syd Labs Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Syd Labs Recent Developments and Future Plans
2.4 Promab
2.4.1 Promab Details
2.4.2 Promab Major Business
2.4.3 Promab Monoclonal Antibody Development Services Product and Solutions
2.4.4 Promab Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Promab Recent Developments and Future Plans
2.5 Antibodies Inc
2.5.1 Antibodies Inc Details
2.5.2 Antibodies Inc Major Business
2.5.3 Antibodies Inc Monoclonal Antibody Development Services Product and Solutions
2.5.4 Antibodies Inc Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Antibodies Inc Recent Developments and Future Plans
2.6 Bhat Biotech
2.6.1 Bhat Biotech Details
2.6.2 Bhat Biotech Major Business
2.6.3 Bhat Biotech Monoclonal Antibody Development Services Product and Solutions
2.6.4 Bhat Biotech Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bhat Biotech Recent Developments and Future Plans
2.7 Synaptic Systems
2.7.1 Synaptic Systems Details
2.7.2 Synaptic Systems Major Business
2.7.3 Synaptic Systems Monoclonal Antibody Development Services Product and Solutions
2.7.4 Synaptic Systems Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Synaptic Systems Recent Developments and Future Plans
2.8 Covalab
2.8.1 Covalab Details
2.8.2 Covalab Major Business
2.8.3 Covalab Monoclonal Antibody Development Services Product and Solutions
2.8.4 Covalab Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Covalab Recent Developments and Future Plans
2.9 CePower
2.9.1 CePower Details
2.9.2 CePower Major Business
2.9.3 CePower Monoclonal Antibody Development Services Product and Solutions
2.9.4 CePower Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 CePower Recent Developments and Future Plans
2.10 Lampire Biological Laboratories
2.10.1 Lampire Biological Laboratories Details
2.10.2 Lampire Biological Laboratories Major Business
2.10.3 Lampire Biological Laboratories Monoclonal Antibody Development Services Product and Solutions
2.10.4 Lampire Biological Laboratories Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Lampire Biological Laboratories Recent Developments and Future Plans
2.11 Leinco Technologies
2.11.1 Leinco Technologies Details
2.11.2 Leinco Technologies Major Business
2.11.3 Leinco Technologies Monoclonal Antibody Development Services Product and Solutions
2.11.4 Leinco Technologies Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Leinco Technologies Recent Developments and Future Plans
2.12 Medimabs
2.12.1 Medimabs Details
2.12.2 Medimabs Major Business
2.12.3 Medimabs Monoclonal Antibody Development Services Product and Solutions
2.12.4 Medimabs Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Medimabs Recent Developments and Future Plans
2.13 Davids Bioengineering
2.13.1 Davids Bioengineering Details
2.13.2 Davids Bioengineering Major Business
2.13.3 Davids Bioengineering Monoclonal Antibody Development Services Product and Solutions
2.13.4 Davids Bioengineering Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Davids Bioengineering Recent Developments and Future Plans
2.14 Scantibodies
2.14.1 Scantibodies Details
2.14.2 Scantibodies Major Business
2.14.3 Scantibodies Monoclonal Antibody Development Services Product and Solutions
2.14.4 Scantibodies Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Scantibodies Recent Developments and Future Plans
2.15 Abwiz Bio
2.15.1 Abwiz Bio Details
2.15.2 Abwiz Bio Major Business
2.15.3 Abwiz Bio Monoclonal Antibody Development Services Product and Solutions
2.15.4 Abwiz Bio Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Abwiz Bio Recent Developments and Future Plans
2.16 Thermo Fisher Scientific
2.16.1 Thermo Fisher Scientific Details
2.16.2 Thermo Fisher Scientific Major Business
2.16.3 Thermo Fisher Scientific Monoclonal Antibody Development Services Product and Solutions
2.16.4 Thermo Fisher Scientific Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Monoclonal Antibody Development Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Monoclonal Antibody Development Services by Company Revenue
3.2.2 Top 3 Monoclonal Antibody Development Services Players Market Share in 2022
3.2.3 Top 6 Monoclonal Antibody Development Services Players Market Share in 2022
3.3 Monoclonal Antibody Development Services Market: Overall Company Footprint Analysis
3.3.1 Monoclonal Antibody Development Services Market: Region Footprint
3.3.2 Monoclonal Antibody Development Services Market: Company Product Type Footprint
3.3.3 Monoclonal Antibody Development Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Monoclonal Antibody Development Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global Monoclonal Antibody Development Services Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Monoclonal Antibody Development Services Consumption Value Market Share by Application (2018-2023)
5.2 Global Monoclonal Antibody Development Services Market Forecast by Application (2024-2029)
6 North America
6.1 North America Monoclonal Antibody Development Services Consumption Value by Type (2018-2029)
6.2 North America Monoclonal Antibody Development Services Consumption Value by Application (2018-2029)
6.3 North America Monoclonal Antibody Development Services Market Size by Country
6.3.1 North America Monoclonal Antibody Development Services Consumption Value by Country (2018-2029)
6.3.2 United States Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
6.3.3 Canada Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
6.3.4 Mexico Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Monoclonal Antibody Development Services Consumption Value by Type (2018-2029)
7.2 Europe Monoclonal Antibody Development Services Consumption Value by Application (2018-2029)
7.3 Europe Monoclonal Antibody Development Services Market Size by Country
7.3.1 Europe Monoclonal Antibody Development Services Consumption Value by Country (2018-2029)
7.3.2 Germany Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
7.3.3 France Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
7.3.5 Russia Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
7.3.6 Italy Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Development Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Monoclonal Antibody Development Services Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Monoclonal Antibody Development Services Market Size by Region
8.3.1 Asia-Pacific Monoclonal Antibody Development Services Consumption Value by Region (2018-2029)
8.3.2 China Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
8.3.3 Japan Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
8.3.4 South Korea Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
8.3.5 India Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
8.3.7 Australia Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
9 South America
9.1 South America Monoclonal Antibody Development Services Consumption Value by Type (2018-2029)
9.2 South America Monoclonal Antibody Development Services Consumption Value by Application (2018-2029)
9.3 South America Monoclonal Antibody Development Services Market Size by Country
9.3.1 South America Monoclonal Antibody Development Services Consumption Value by Country (2018-2029)
9.3.2 Brazil Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
9.3.3 Argentina Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Development Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Monoclonal Antibody Development Services Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Monoclonal Antibody Development Services Market Size by Country
10.3.1 Middle East & Africa Monoclonal Antibody Development Services Consumption Value by Country (2018-2029)
10.3.2 Turkey Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
10.3.4 UAE Monoclonal Antibody Development Services Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Monoclonal Antibody Development Services Market Drivers
11.2 Monoclonal Antibody Development Services Market Restraints
11.3 Monoclonal Antibody Development Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Monoclonal Antibody Development Services Industry Chain
12.2 Monoclonal Antibody Development Services Upstream Analysis
12.3 Monoclonal Antibody Development Services Midstream Analysis
12.4 Monoclonal Antibody Development Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer